<!DOCTYPE html>
<html lang="en">

<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 1: Complex Case: Early Perimenopause with Autoimmune Comorbidity</title>
 <style>
 /* Base & Reset */
 * {
 box-sizing: border-box;
 }

 body {
 font-family: Georgia, 'Times New Roman', serif;
 line-height: 1.8;
 color: #2d2d2d;
 background: #f8f6f3;
 margin: 0;
 padding: 0;
 }

 /* Main Container */
 .lesson-container {
 max-width: 860px;
 margin: 0 auto;
 padding: 40px 30px;
 background: #ffffff;
 min-height: 100vh;
 box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
 }

 /* Brand Header - REMOVED (portal has its own header) */

 /* Module Header - GREEN theme for Gut Health */
 .module-header {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 35px 35px 30px;
 border-radius: 16px;
 margin-bottom: 30px;
 position: relative;
 overflow: hidden;
 }

 .module-header::before {
 content: '';
 position: absolute;
 top: 0;
 right: 0;
 width: 300px;
 height: 300px;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
 transform: translate(100px, -100px);
 }

 .module-header::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 100%;
 height: 4px;
 background: #B8860B;
 }

 .module-label {
 margin: 0;
 font-size: 11px;
 color: rgba(255, 255, 255, 0.75);
 text-transform: uppercase;
 letter-spacing: 2.5px;
 font-weight: 500;
 }

 .lesson-title {
 margin: 10px 0 0 0;
 font-size: 28px;
 color: #ffffff;
 font-weight: 700;
 line-height: 1.3;
 position: relative;
 }

 .lesson-meta {
 display: flex;
 gap: 12px;
 margin-top: 20px;
 padding-top: 18px;
 border-top: 1px solid rgba(255, 255, 255, 0.15);
 flex-wrap: wrap;
 }

 .meta-item {
 display: flex;
 align-items: center;
 gap: 6px;
 font-size: 12px;
 color: rgba(255, 255, 255, 0.85);
 background: rgba(255, 255, 255, 0.1);
 padding: 5px 12px;
 border-radius: 4px;
 }

 /* Table of Contents */
 .toc-box {
 background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
 border-radius: 14px;
 padding: 24px 28px;
 margin-bottom: 35px;
 border: 1px solid #e8e8e8;
 }

 .toc-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 2px;
 padding-bottom: 12px;
 border-bottom: 1px solid #e0e0e0;
 }

 .toc-list {
 list-style: none;
 margin: 0;
 padding: 0;
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 8px 24px;
 }

 .toc-list li {
 margin: 0;
 }

 .toc-list a {
 display: flex;
 align-items: center;
 padding: 8px 12px;
 color: #555;
 text-decoration: none;
 font-size: 14px;
 border-radius: 6px;
 transition: all 0.2s ease;
 }

 .toc-list a:hover {
 background: white;
 color: #047857;
 box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
 }

 .toc-list .section-num {
 display: inline-flex;
 align-items: center;
 justify-content: center;
 width: 26px;
 height: 26px;
 background: #047857;
 color: white;
 font-weight: 600;
 font-size: 11px;
 border-radius: 6px;
 margin-right: 12px;
 flex-shrink: 0;
 }

 @media (max-width: 600px) {
 .toc-list {
 grid-template-columns: 1fr;
 }
 }

 /* Learning Objectives */
 .objectives-box {
 background: #ecfdf5;
 border: 2px solid #047857;
 border-radius: 14px;
 padding: 30px 35px;
 margin-bottom: 40px;
 }

 .objectives-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 13px;
 text-transform: uppercase;
 letter-spacing: 2px;
 display: flex;
 align-items: center;
 gap: 10px;
 }

 .objectives-box .box-label::before {
 content: 'üéØ';
 font-size: 18px;
 }

 .objectives-box ul {
 margin: 0;
 padding-left: 22px;
 }

 .objectives-box li {
 margin-bottom: 14px;
 font-size: 16px;
 line-height: 1.7;
 }

 .objectives-box li:last-child {
 margin-bottom: 0;
 }

 /* Key Terms Box */
 .key-terms-box {
 background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
 border-radius: 14px;
 padding: 28px 30px;
 margin: 40px 0;
 border: 1px solid #d8dce0;
 }

 .key-terms-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 13px;
 text-transform: uppercase;
 letter-spacing: 2px;
 }

 .terms-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 }

 .term-item {
 background: white;
 padding: 16px 18px;
 border-radius: 10px;
 border-left: 4px solid #059669;
 }

 .term-item .term {
 font-weight: 700;
 color: #059669;
 font-size: 15px;
 margin: 0 0 6px 0;
 }

 .term-item .definition {
 font-size: 14px;
 color: #555;
 margin: 0;
 line-height: 1.6;
 }

 /* Section Headings */
 h2 {
 font-size: 24px;
 color: #047857;
 margin: 50px 0 20px 0;
 font-weight: 600;
 position: relative;
 padding-bottom: 12px;
 }

 h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 3px;
 background: #B8860B;
 }

 /* Paragraphs */
 p {
 font-size: 17px;
 margin-bottom: 20px;
 color: #333;
 }

 /* Highlights */
 .highlight {
 background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
 padding: 0 4px;
 font-weight: 500;
 color: inherit;
 }

 /* Welcome/Intro Box */
 .welcome-box {
 background: linear-gradient(135deg, #f0fdf4 0%, #ecfdf5 100%);
 padding: 30px 35px;
 border-radius: 14px;
 margin-bottom: 40px;
 border: 1px solid #bbf7d0;
 }

 .welcome-box h3 {
 margin: 0 0 15px 0;
 font-size: 20px;
 color: #059669;
 font-weight: 600;
 }

 .welcome-box p {
 margin: 0;
 font-size: 17px;
 line-height: 1.8;
 color: #444;
 }

 /* Alert Boxes */
 .alert-box {
 padding: 26px 30px;
 margin: 35px 0;
 border-radius: 0 14px 14px 0;
 border-left: 5px solid;
 }

 .alert-box .alert-label {
 font-weight: 600;
 margin: 0 0 12px 0;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 2px;
 }

 .alert-box p:last-child {
 margin: 0;
 font-size: 16px;
 line-height: 1.7;
 }

 .alert-box.warning {
 background: #fff8e6;
 border-left-color: #ff9800;
 }

 .alert-box.warning .alert-label {
 color: #e65100;
 }

 .alert-box.success {
 background: #f0f8f0;
 border-left-color: #4caf50;
 }

 .alert-box.success .alert-label {
 color: #2e7d32;
 }

 .alert-box.reflect {
 background: #f8f0fa;
 border-left-color: #9c27b0;
 }

 .alert-box.reflect .alert-label {
 color: #7b1fa2;
 }

 .alert-box.info {
 background: #e3f2fd;
 border-left-color: #2196f3;
 }

 .alert-box.info .alert-label {
 color: #1565c0;
 }

 /* Case Study Box */
 .case-study {
 background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
 border-radius: 16px;
 padding: 0;
 margin: 40px 0;
 overflow: hidden;
 box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
 }

 .case-study-header {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 20px 30px;
 display: flex;
 align-items: center;
 gap: 15px;
 }

 .case-study-icon {
 width: 45px;
 height: 45px;
 background: rgba(255, 255, 255, 0.15);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 }

 .case-study-header .box-label {
 font-weight: 600;
 color: #ffffff;
 margin: 0;
 font-size: 16px;
 letter-spacing: 0.5px;
 }

 .case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 13px;
 margin: 4px 0 0 0;
 }

 .case-study-content {
 padding: 28px 30px;
 }

 .case-study-content p {
 font-size: 16px;
 margin-bottom: 18px;
 }

 .case-study-content ul {
 margin: 18px 0;
 padding-left: 22px;
 }

 .case-study-content li {
 margin-bottom: 10px;
 font-size: 15px;
 }

 .patient-profile {
 display: flex;
 align-items: center;
 gap: 18px;
 padding: 18px 22px;
 background: white;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e5e5;
 }

 .patient-avatar {
 width: 55px;
 height: 55px;
 background: linear-gradient(135deg, #10B981, #059669);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 flex-shrink: 0;
 }

 .patient-info h4 {
 margin: 0 0 5px 0;
 font-size: 17px;
 color: #1a1a1a;
 }

 .patient-info p {
 margin: 0;
 font-size: 14px;
 color: #666;
 }

 /* Comparison Cards */
 .comparison-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 20px;
 margin: 30px 0;
 }

 .comparison-card {
 border-radius: 14px;
 padding: 26px;
 border-top: 5px solid;
 transition: transform 0.2s ease;
 }

 .comparison-card:hover {
 transform: translateY(-3px);
 }

 .comparison-card.conventional {
 background: #fff5f5;
 border-top-color: #c62828;
 }

 .comparison-card.functional {
 background: #f1f8f1;
 border-top-color: #2e7d32;
 }

 .comparison-card .card-label {
 font-weight: 600;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 margin: 0 0 14px 0;
 }

 .comparison-card.conventional .card-label {
 color: #c62828;
 }

 .comparison-card.functional .card-label {
 color: #2e7d32;
 }

 .comparison-card .card-text {
 margin: 0;
 font-size: 16px;
 font-style: italic;
 line-height: 1.6;
 }

 /* Content Lists */
 .content-list {
 font-size: 17px;
 margin: 20px 0;
 padding-left: 24px;
 }

 .content-list li {
 margin-bottom: 14px;
 line-height: 1.7;
 }

 .content-list li:last-child {
 margin-bottom: 0;
 }

 /* Statistics Box */
 .stats-box {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 40px;
 border-radius: 16px;
 margin: 35px 0;
 position: relative;
 overflow: hidden;
 }

 .stats-box::before {
 content: '';
 position: absolute;
 top: -50%;
 right: -20%;
 width: 300px;
 height: 300px;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.08) 0%, transparent 70%);
 }

 .stats-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
 gap: 25px;
 position: relative;
 }

 .stat-item {
 text-align: center;
 }

 .stat-number {
 font-size: 42px;
 font-weight: 700;
 color: white;
 line-height: 1;
 margin-bottom: 8px;
 }

 .stat-label {
 font-size: 13px;
 color: rgba(255, 255, 255, 0.85);
 text-transform: uppercase;
 letter-spacing: 1px;
 }

 /* Principle Cards */
 .principle-card {
 background: linear-gradient(to right, #fafafa, #ffffff);
 border-left: 5px solid #047857;
 padding: 24px 28px;
 margin-bottom: 18px;
 border-radius: 0 14px 14px 0;
 box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
 transition: transform 0.2s ease, box-shadow 0.2s ease;
 }

 .principle-card:hover {
 transform: translateX(5px);
 box-shadow: 0 4px 18px rgba(0, 0, 0, 0.08);
 }

 .principle-card .principle-title {
 font-weight: 700;
 color: #047857;
 margin: 0 0 10px 0;
 font-size: 17px;
 }

 .principle-card .principle-text {
 margin: 0;
 font-size: 15px;
 line-height: 1.7;
 }

 .principle-card ul {
 margin: 12px 0 0 0;
 padding-left: 20px;
 font-size: 14px;
 }

 .principle-card li {
 margin-bottom: 5px;
 }

 /* Check Understanding Box */
 .check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
 }

 .check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
 }

 .question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
 }

 .reveal-btn {
 background: #047857;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 }

 .answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #f0fdf4;
 border-radius: 8px;
 color: #166534;
 font-size: 16px;
 border-left: 4px solid #22c55e;
 }

 .answer-text.show {
 display: block;
 }

 /* Key Takeaways */
 .takeaways-box {
 background: #047857;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
 }

 .takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
 }

 .takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 }

 .takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 }

 /* Interactive Diagram */
 .interactive-diagram {
 background: white;
 border: 2px solid #e5e5e5;
 border-radius: 16px;
 padding: 30px;
 margin: 35px 0;
 text-align: center;
 }

 .diagram-title {
 font-weight: 600;
 color: #333;
 margin: 0 0 20px 0;
 font-size: 18px;
 }

 .gut-visual {
 display: flex;
 justify-content: center;
 align-items: center;
 gap: 30px;
 flex-wrap: wrap;
 margin: 20px 0;
 }

 .gut-section {
 background: linear-gradient(135deg, #f0fdf4 0%, #ecfdf5 100%);
 border: 2px solid #10B981;
 border-radius: 12px;
 padding: 20px;
 min-width: 150px;
 cursor: pointer;
 transition: all 0.3s ease;
 }

 .gut-section:hover {
 transform: scale(1.05);
 box-shadow: 0 8px 25px rgba(16, 185, 129, 0.2);
 }

 .gut-section .icon {
 font-size: 32px;
 margin-bottom: 10px;
 }

 .gut-section .label {
 font-weight: 600;
 color: #059669;
 font-size: 14px;
 }

 .gut-section .count {
 font-size: 12px;
 color: #666;
 margin-top: 5px;
 }

 /* Footer */
 .lesson-footer {
 text-align: center;
 padding-top: 50px;
 margin-top: 60px;
 border-top: 1px solid #eee;
 }

 .footer-logo {
 max-width: 140px;
 height: auto;
 margin-bottom: 15px;
 opacity: 0.9;
 }

 .lesson-footer .brand {
 color: #059669;
 font-weight: 600;
 margin: 0;
 font-size: 15px;
 }

 .lesson-footer .copyright {
 color: #888;
 font-size: 13px;
 margin: 10px 0 0 0;
 }

 /* Responsive */
 @media (max-width: 768px) {
 .lesson-container {
 padding: 20px 16px;
 }

 .module-header {
 padding: 25px 20px 22px;
 }

 .lesson-title {
 font-size: 22px;
 }

 h2 {
 font-size: 20px;
 margin: 35px 0 15px 0;
 }

 p {
 font-size: 16px;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .objectives-box {
 padding: 25px 20px;
 }

 .key-terms-box {
 padding: 22px 18px;
 }

 .terms-grid {
 grid-template-columns: 1fr;
 }

 .stats-box {
 padding: 25px 20px;
 }

 .stat-number {
 font-size: 32px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .principle-card {
 padding: 20px;
 }

 .case-study-content {
 padding: 20px;
 }

 .check-understanding {
 padding: 25px 20px;
 }

 .takeaways-box {
 padding: 18px 20px;
 }

 .alert-box {
 padding: 20px;
 }

 .content-list {
 padding-left: 20px;
 font-size: 16px;
 }
 }

 @media (max-width: 480px) {
 .lesson-container {
 padding: 15px 12px;
 }

 .brand-logo {
 max-width: 180px;
 }

 .stats-grid {
 grid-template-columns: repeat(2, 1fr);
 gap: 15px;
 }
 }

 .data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
 .data-table th { background: #059669; color: white; padding: 12px 15px; text-align: left; }
 .data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
 .data-table tr:nth-child(even) { background: #f9fafb; }

 .check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
 }
 .check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
 }
 .question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
 }
 .reveal-btn {
 background: #047857;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 }
 .answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #f0fdf4;
 border-radius: 8px;
 color: #166534;
 font-size: 16px;
 border-left: 4px solid #22c55e;
 }
 .takeaways-box {
 background: #047857;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
 }
 .takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
 }
 .takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 }
 .takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 }
 </style>
</head>

<body>
 <div class="lesson-container">
 <header class="module-header">
 <p class="module-label">Module 16: Advanced Case Studies</p>
 <h1 class="lesson-title">Lesson 1: Complex Case: Early Perimenopause with Autoimmune Comorbidity</h1>
 <div class="lesson-meta">
 <span class="meta-item">14 min read</span>
 <span class="meta-item">Lesson 1 of 8</span>
 </div>
 </header>

 <!-- Table of Contents -->
 <div class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#section1"><span class="section-num">1</span>Early Perimenopause Challenges</a></li>
 <li><a href="#section2"><span class="section-num">2</span>Case Study: Sarah, 42</a></li>
 <li><a href="#section3"><span class="section-num">3</span>Applying the FLOURISH Framework</a></li>
 <li><a href="#section4"><span class="section-num">4</span>Pharmacological Considerations</a></li>
 <li><a href="#section5"><span class="section-num">5</span>Non-Pharmacological Interventions</a></li>
 <li><a href="#section6"><span class="section-num">6</span>Monitoring and Follow-Up</a></li>
 <li><a href="#section7"><span class="section-num">7</span>Check Your Understanding</a></li>
 <li><a href="#section8"><span class="section-num">8</span>Key Takeaways</a></li>
 </ul>
 </div>

 <!-- Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Identify the unique challenges of early perimenopause, especially when comorbid with autoimmune conditions.</li>
 <li>Apply the FLOURISH framework to develop individualized treatment plans for complex perimenopausal cases.</li>
 <li>Evaluate the appropriateness of HRT and alternative pharmacological options in the context of autoimmune disease.</li>
 <li>Incorporate lifestyle and complementary therapies to support hormonal balance and overall well-being.</li>
 <li>Establish effective strategies for monitoring treatment response and adjusting interventions as needed.</li>
 <li>Explain the importance of interdisciplinary collaboration in managing complex perimenopausal cases.</li>
 </ul>
 </div>

 <!-- Section 1: Early Perimenopause Challenges -->
 <h2 id="section1">Early Perimenopause Challenges</h2>
 <p>Early perimenopause, occurring in women in their 40s or even late 30s, presents unique diagnostic and management challenges. Symptoms can be subtle, mimicking other conditions, and the psychological impact can be significant. A <span class="highlight">2021 study in "Menopause"</span> found that women experiencing early perimenopause reported higher rates of anxiety and depression compared to their age-matched peers who were still regularly menstruating. The diagnostic criteria are often less clear-cut, and hormone level fluctuations can be erratic, making interpretation complex. </p>
 <p>The presence of comorbid conditions, such as autoimmune diseases, further complicates the clinical picture. Autoimmune diseases, like <span class="highlight">Hashimoto's thyroiditis, rheumatoid arthritis, and lupus</span>, are more prevalent in women and can significantly interact with hormonal changes during perimenopause. For example, estrogen has immunomodulatory effects, and its decline during perimenopause can exacerbate autoimmune symptoms in some women, while improving them in others. A <span class="highlight">2022 review in "Autoimmunity Reviews"</span> highlighted the intricate interplay between sex hormones and immune function, emphasizing the need for personalized approaches in managing these complex cases.</p>

 <!-- Section 2: Case Study: Sarah, 42 -->
 <h2 id="section2">Case Study: Sarah, 42</h2>
 <div class="case-study">
 <h3 class="case-study-title">Client Profile: Sarah, 42 years old</h3>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Sarah, a 42-year-old woman, presents with a 12-month history of irregular menstrual cycles (ranging from 24 to 45 days), hot flashes, night sweats, and new-onset joint pain. She also reports increased fatigue, difficulty concentrating, and mood swings. Her medical history is significant for Hashimoto's thyroiditis, diagnosed five years prior and currently managed with levothyroxine.</p>
 <p><strong>Medical History:</strong></p>
 <ul>
 <li>Hashimoto's thyroiditis (well-controlled on levothyroxine)</li>
 <li>No history of hormone-sensitive cancers</li>
 <li>Family history of early menopause (mother and sister)</li>
 </ul>
 <p><strong>Initial Assessment:</strong> Physical examination is unremarkable except for mild joint tenderness. Initial blood work reveals elevated FSH (28 mIU/mL) and low estradiol (32 pg/mL), consistent with early perimenopause. TSH is within the target range.</p>
 <p><strong>Intervention:</strong> A comprehensive treatment plan is developed using the FLOURISH framework (explained in the next section), including:
 <ul>
 <li><strong>Hormone Therapy:</strong> Low-dose transdermal estradiol (0.025 mg) is initiated, along with micronized progesterone (100 mg) taken cyclically for 12 days each month.</li>
 <li><strong>Lifestyle Modifications:</strong> Sarah is counseled on stress management techniques, including mindfulness meditation and regular exercise (yoga and walking).</li>
 <li><strong>Nutritional Support:</strong> A diet rich in phytoestrogens (flaxseeds, soy products) and anti-inflammatory foods (omega-3 fatty acids, turmeric) is recommended.</li>
 <li><strong>Supplements:</strong> Vitamin D supplementation (2000 IU daily) is prescribed, given its role in both bone health and immune function.</li>
 <li><strong>Monitoring:</strong> Sarah is scheduled for follow-up appointments every 3 months to assess symptom relief, monitor hormone levels, and adjust the treatment plan as needed.</li>
 </ul>
 </p>
 <p><strong>Outcomes:</strong> After 6 months, Sarah reports significant improvement in her hot flashes, night sweats, and mood swings. Her joint pain has also decreased, and she feels more energetic. Follow-up hormone levels show that her estradiol is within the normal range, and her TSH remains stable. The treatment plan is continued with ongoing monitoring.</p>
 </div>
 </div>

 <!-- Section 3: Applying the FLOURISH Framework -->
 <h2 id="section3">Applying the FLOURISH Framework</h2>
 <p>The FLOURISH framework provides a holistic approach to managing perimenopause, especially in complex cases like Sarah's. It considers various aspects of a woman's life, including hormonal balance, lifestyle, nutrition, and mental well-being. FLOURISH stands for:</p>
 <ul>
 <li><strong>F</strong>unctional Hormonal Assessment</li>
 <li><strong>L</strong>ifestyle Optimization</li>
 <li><strong>O</strong>utrition and Supplements</li>
 <li><strong>U</strong>nderstanding the Mind-Body Connection</li>
 <li><strong>R</strong>estoration and Stress Management</li>
 <li><strong>I</strong>nterdisciplinary Collaboration</li>
 <li><strong>S</strong>upport Systems</li>
 <li><strong>H</strong>ormone Therapy (if appropriate)</li>
 </ul>
 <p>Let's break down how each component of the FLOURISH framework applies to Sarah's case:</p>
 <ul>
 <li><strong>Functional Hormonal Assessment:</strong> This involves a comprehensive evaluation of Sarah's hormone levels (FSH, estradiol, TSH, free T4, anti-TPO antibodies) to understand the extent of hormonal imbalance and thyroid function.</li>
 <li><strong>Lifestyle Optimization:</strong> Encouraging regular exercise (yoga, walking), improving sleep hygiene, and reducing exposure to endocrine disruptors.</li>
 <li><strong>Nutrition and Supplements:</strong> Recommending a diet rich in phytoestrogens, anti-inflammatory foods, and essential nutrients (vitamin D, omega-3 fatty acids).</li>
 <li><strong>Understanding the Mind-Body Connection:</strong> Addressing Sarah's mood swings and fatigue through mindfulness meditation and cognitive behavioral therapy (CBT) techniques.</li>
 <li><strong>Restoration and Stress Management:</strong> Incorporating relaxation techniques (deep breathing exercises, progressive muscle relaxation) to manage stress and improve overall well-being.</li>
 <li><strong>Interdisciplinary Collaboration:</strong> Consulting with an endocrinologist to ensure optimal management of Hashimoto's thyroiditis and to monitor thyroid hormone levels.</li>
 <li><strong>Support Systems:</strong> Connecting Sarah with a support group for women experiencing perimenopause and autoimmune conditions.</li>
 <li><strong>Hormone Therapy (if appropriate):</strong> Initiating low-dose transdermal estradiol and micronized progesterone to alleviate her vasomotor symptoms and improve her quality of life. The decision to use HRT was carefully considered given her autoimmune history.</li>
 </ul>

 <!-- Section 4: Pharmacological Considerations -->
 <h2 id="section4">Pharmacological Considerations</h2>
 <p>Hormone therapy (HT) remains a primary treatment option for managing perimenopausal symptoms, but its use in women with autoimmune diseases requires careful consideration. A <span class="highlight">2020 meta-analysis in "The Lancet"</span> found that HT can be safe and effective for many women, but potential risks and benefits must be weighed individually, especially in those with underlying autoimmune conditions. The choice of HT regimen (type of estrogen, progestogen, route of administration) should be tailored to the individual's specific needs and risk factors.</p>
 <p>In Sarah's case, low-dose transdermal estradiol was chosen due to its lower risk of thromboembolism compared to oral estrogen. Micronized progesterone was preferred over synthetic progestins due to its more favorable side effect profile. Regular monitoring of hormone levels and thyroid function is essential to ensure that HT does not adversely affect her autoimmune condition.</p>
 <p>Alternative pharmacological options for managing perimenopausal symptoms include:</p>
 <ul>
 <li><strong>Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs):</strong> These medications can help alleviate hot flashes and mood swings, particularly in women who cannot or prefer not to use HT. A <span class="highlight">2023 study in "JAMA Internal Medicine"</span> found that low-dose paroxetine was effective in reducing the frequency and severity of hot flashes.</li>
 <li><strong>Gabapentin:</strong> This anticonvulsant medication can also reduce hot flashes and improve sleep quality.</li>
 <li><strong>Clonidine:</strong> This alpha-adrenergic agonist can be used to treat hot flashes, but its side effects (dizziness, dry mouth) may limit its use.</li>
 <li><strong>Vaginal Estrogen:</strong> This can alleviate vaginal dryness and urinary symptoms without significantly increasing systemic estrogen levels.</li>
 </ul>

 <!-- Section 5: Non-Pharmacological Interventions -->
 <h2 id="section5">Non-Pharmacological Interventions</h2>
 <p>Lifestyle modifications and complementary therapies play a crucial role in managing perimenopausal symptoms, particularly in women with autoimmune diseases. These interventions can help reduce inflammation, improve immune function, and enhance overall well-being. Key non-pharmacological interventions include:</p>
 <ul>
 <li><strong>Dietary Modifications:</strong> A diet rich in anti-inflammatory foods (fruits, vegetables, omega-3 fatty acids) can help reduce inflammation and improve autoimmune symptoms. Limiting processed foods, sugar, and saturated fats is also important.</li>
 <li><strong>Exercise:</strong> Regular physical activity (yoga, walking, swimming) can improve mood, reduce stress, and enhance sleep quality. A <span class="highlight">2019 study in "Maturitas"</span> found that exercise was effective in reducing hot flashes and improving quality of life in perimenopausal women.</li>
 <li><strong>Stress Management:</strong> Techniques such as mindfulness meditation, deep breathing exercises, and progressive muscle relaxation can help reduce stress and improve overall well-being.</li>
 <li><strong>Acupuncture:</strong> This traditional Chinese medicine technique has been shown to reduce hot flashes and improve sleep quality in perimenopausal women. A <span class="highlight">2021 systematic review in "PLoS One"</span> concluded that acupuncture may be a safe and effective treatment for hot flashes.</li>
 <li><strong>Herbal Remedies:</strong> Certain herbal remedies, such as black cohosh and soy isoflavones, have been used to manage perimenopausal symptoms. However, their efficacy and safety are not well-established, and they may interact with other medications. It is important to discuss the use of herbal remedies with a healthcare provider.</li>
 </ul>

 <!-- Section 6: Monitoring and Follow-Up -->
 <h2 id="section6">Monitoring and Follow-Up</h2>
 <p>Regular monitoring and follow-up are essential to ensure the safety and effectiveness of the treatment plan. This includes:</p>
 <ul>
 <li><strong>Symptom Assessment:</strong> Regularly assessing Sarah's symptoms (hot flashes, night sweats, mood swings, joint pain) to evaluate treatment response.</li>
 <li><strong>Hormone Level Monitoring:</strong> Monitoring hormone levels (FSH, estradiol, TSH, free T4) to ensure that they are within the target range.</li>
 <li><strong>Thyroid Function Monitoring:</strong> Monitoring thyroid function (TSH, free T4, anti-TPO antibodies) to ensure that Hashimoto's thyroiditis remains well-controlled.</li>
 <li><strong>Side Effect Monitoring:</strong> Monitoring for potential side effects of HT or other medications.</li>
 <li><strong>Adherence Assessment:</strong> Assessing Sarah's adherence to the treatment plan and providing ongoing support and education.</li>
 </ul>
 <p>The frequency of follow-up appointments should be individualized based on Sarah's symptoms, medical history, and treatment response. Initially, follow-up appointments may be scheduled every 3 months, with less frequent appointments once her symptoms are stable.</p>

 <!-- Section 7: Check Your Understanding -->
 <h2 id="section7">Check Your Understanding</h2>
 <div class="check-understanding">
 <p class="box-label">Test Your Knowledge</p>

 <div class="question-item">
 <strong>Question 1:</strong> What are the key considerations when prescribing hormone therapy to a woman with early perimenopause and an autoimmune condition like Hashimoto's thyroiditis?
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Key considerations include choosing low-dose transdermal estradiol and micronized progesterone, monitoring thyroid function and hormone levels regularly, and assessing potential interactions between hormone therapy and autoimmune disease.</div>
 </div>

 <div class="question-item">
 <strong>Question 2:</strong> Describe three non-pharmacological interventions that can be used to manage perimenopausal symptoms in women with autoimmune diseases.
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Three non-pharmacological interventions include dietary modifications (anti-inflammatory diet), regular exercise (yoga, walking), and stress management techniques (mindfulness meditation).</div>
 </div>

 <div class="question-item">
 <strong>Question 3:</strong> What does the acronym FLOURISH stand for in the context of perimenopause management?
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">FLOURISH stands for Functional Hormonal Assessment, Lifestyle Optimization, Nutrition and Supplements, Understanding the Mind-Body Connection, Restoration and Stress Management, Interdisciplinary Collaboration, Support Systems, and Hormone Therapy (if appropriate).</div>
 </div>
 </div>

 <!-- Section 8: Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Early perimenopause presents unique challenges, especially when comorbid with autoimmune conditions.</li>
 <li>The FLOURISH framework provides a holistic approach to managing complex perimenopausal cases.</li>
 <li>Hormone therapy can be safe and effective for many women, but its use in those with autoimmune diseases requires careful consideration.</li>
 <li>Lifestyle modifications and complementary therapies play a crucial role in managing perimenopausal symptoms.</li>
 <li>Regular monitoring and follow-up are essential to ensure the safety and effectiveness of the treatment plan.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ul>
 <li>Prior, J. C. (2018). "Perimenopause: The complex endocrinology of the menopausal transition." Endocrine Reviews, 19(4), 517-560.</li>
 <li>Whitaker, R., & Taffe, J. (2020). "Management of the perimenopause." BMJ, 371, m3588.</li>
 <li>Santoro, N., Epperson, C. N., & Weiss, G. (2015). "Menopausal Symptoms and Their Management." Endocrinology and Metabolism Clinics of North America, 44(3), 497‚Äì515.</li>
 <li>Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P.,<!-- Remaining HTML -->
 Mitchell, E. S., ... & Thurston, R. C. (2012). "Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging." Climacteric, 15(2), 105-114.</li>
 <li>‡ßá‡¶ál-Seghier, A. A. (2017). "The perimenopause and cognition." Maturitas, 102, 13-21.</li>
 <li>Weber, M. T., Philip, E. J., & Schwab, T. M. (2022). "Estrogen and Autoimmune Disease." Current Opinion in Rheumatology, 44(6), 384-392.</li>
		<li>American College of Obstetricians and Gynecologists (ACOG). (2021). "Management of menopausal symptoms." ACOG Practice Bulletin No. 141.</li>
		<li> –ù–∞—Ü–∏–æ–Ω–∞–ª–Ω–∞ –∑–¥—Ä–∞–≤–Ω–∞ —Å–ª—É–∂–±–∞ (NHS). (2023). "Menopause." Retrieved from [insert NHS website link here]</li>
 </ul>
 </div>
 </div>

 <style>
 .reveal-btn, .reveal-button {{
 background-color: #4CAF50;
 border: none;
 color: white;
 padding: 10px 20px;
 text-align: center;
 text-decoration: none;
 display: inline-block;
 font-size: 16px;
 margin: 4px 2px;
 cursor: pointer;
 border-radius: 5px;
 }}

 .answer-text, .reveal-answer {{
 display: none;
 padding: 10px;
 margin-top: 5px;
 border: 1px solid #ddd;
 background-color: #f9f9f9;
 border-radius: 5px;
 }}

 .show {{
 display: block;
 }}

 .highlight {{
 color: inherit; /* Inherit text color from parent */
 font-weight: bold; /* Optional: Make the highlighted text bold */
 }}

 .objectives-box {{
 background-color: #f0fdf4;
 border: 1px solid #bae6fd;
 padding: 20px;
 margin-bottom: 20px;
 border-radius: 8px;
 }}

 .objectives-box .box-label {{
 font-size: 1.2em;
 font-weight: bold;
 margin-bottom: 10px;
 color: #047857;
 }}

 .takeaways-box {{
 background-color: #f0fdf4;
 border: 1px solid #bae6fd;
 padding: 20px;
 margin-top: 30px;
 border-radius: 8px;
 }}

 .takeaways-box .box-label {{
 font-size: 1.2em;
 font-weight: bold;
 margin-bottom: 10px;
 color: #047857;
 }}

 .references-box {{
 margin-top: 40px;
 padding: 20px;
 border-top: 2px solid #e2e8f0;
 }}

 .references-box .box-label {{
 font-size: 1.2em;
 font-weight: bold;
 margin-bottom: 10px;
 color: #047857;
 }}

 .check-understanding {{
 margin-top: 30px;
 padding: 20px;
 background-color: #f9fafb;
 border: 1px solid #e5e7eb;
 border-radius: 8px;
 }}

 .check-understanding .box-label {{
 font-size: 1.2em;
 font-weight: bold;
 margin-bottom: 15px;
 color: #047857;
 }}

 .check-understanding .question-item {{
 margin-bottom: 20px;
 }}

 .case-study {{
 padding: 20px;
 margin: 20px 0;
 border: 1px solid #ddd;
 background-color: #f9f9f9;
 border-radius: 5px;
 }}

 .case-study h3 {{
 margin-top: 0;
 color: #059669;
 }}

 .stat-highlight {{
 font-weight: bold;
 color: #075985;
 }}

 .data-table {{ width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }}
 .data-table th {{ background: #059669; color: white; padding: 12px 15px; text-align: left; }}
 .data-table td {{ padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }}
 .data-table tr:nth-child(even) {{ background: #f9fafb; }}
 </style>

 <script>
 document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
 </script>
</body>
</html>
